rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Carmen Chang

Director

Company insider

Files Form 4 as: Director, Coursera; 10% owner, Korro Bio; 10% owner, SpyGlass Pharma; Director and 10% owner, NeueHealth; 10% owner, Trevi Therapeutics; 10% owner, MBX Biosciences; 10% owner, Savara; 10% owner, Mirum Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
164
Buys
19
Sells
7
Bought
$193.8M
Sold
$1.3M
Companies
14
Companies where not an officer
14
First trade
14 Feb 2019
Last trade
11 Jun 2026
Last filed
15 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
COUR CourseraDirector · Software · last 11 Jun 20260 buys · 1 sell
KRRO Korro Bio10% owner · Biotechnology · last 10 Mar 20262 buys · 0 sells
SGP SpyGlass Pharma10% owner · Medical Devices · last 9 Feb 20261 buy · 0 sells
NeueHealthDirector, 10% owner · last 2 Oct 20251 buy · 1 sell
TRVI Trevi Therapeutics10% owner · Biotechnology · last 17 Apr 20253 buys · 1 sell
MBX MBX Biosciences10% owner · Biotechnology · last 16 Sep 20241 buy · 0 sells
SVRA Savara10% owner · Biotechnology · last 17 Jul 20231 buy · 0 sells
MIRM Mirum Pharmaceuticals10% owner · Biotechnology · last 13 Jun 20231 buy · 0 sells
Akouos10% owner · last 30 Nov 20221 buy · 0 sells
Genocea Biosciences10% owner · last 25 May 20223 buys · 2 sells
Metacrine10% owner · last 22 Dec 20211 buy · 2 sells
GLUE Monte Rosa Therapeutics10% owner · Biotechnology · last 28 Jun 20211 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 15 Jun 2026COUR CourseraSoftwareSEC FORM 4 Code A—34,260 at $0.00filing
11 Jun 2026filed 15 Jun 2026COUR CourseraSoftwareSEC FORM 4 Code A—34,260 at $0.00filing
10 Mar 2026filed 12 Mar 2026KRRO Korro BioBiotechnologySEC FORM 4 Bought$2.3M207,100 at $11.11filing
10 Mar 2026filed 12 Mar 2026KRRO Korro Biooption or derivative · BiotechnologySEC FORM 4 Code P$2.7M242,945 at $11.11filing
10 Mar 2026filed 12 Mar 2026KRRO Korro Biooption or derivative · BiotechnologySEC FORM 4 Code P$2.7M242,945 at $11.11filing
10 Mar 2026filed 12 Mar 2026KRRO Korro BioBiotechnologySEC FORM 4 Bought$2.3M207,100 at $11.11filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass PharmaMedical DevicesSEC FORM 4 Code C—1,619,240filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—1,370,168filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—737,962filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—954,990filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—402,273filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass PharmaMedical DevicesSEC FORM 4 Code C—1,370,168filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass PharmaMedical DevicesSEC FORM 4 Code C—1,370,168filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—1,619,240filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—1,370,168filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—1,370,168filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—737,962filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—954,990filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass Pharmaoption or derivative · Medical DevicesSEC FORM 4 Code C—402,273filing
9 Feb 2026filed 11 Feb 2026SGP SpyGlass PharmaMedical DevicesSEC FORM 4 Code C—737,962filing

Sectors

Health Care12
Technology1
Not placed13

Buys in green, sells in red, by the company’s sector.

Related people

Thomas I. SavageSVP, Chief Legal Officer · SVP, Chief Legal Officer at Coursera, filing Form 4 there in the last year
Gregory M. HartPresident & CEO · President & CEO at Coursera, filing Form 4 there in the last year
Pale Fire Capital SE10% owner · 10% owner at Coursera, filing Form 4 there in the last year
Jean Francois FormelaDirector · Director at Korro Bio, filing Form 4 there in the last year
Oliver DolanSenior Vice President, Finance · Senior Vice President, Finance at Korro Bio, filing Form 4 there in the last year
Matthew BowenPrincipal Accounting Officer · Also traded GLUE in the last 90 days
Michael Thomas HeffernanDirector · Also traded TRVI in the last 90 days
Eric BjerkholtChief Financial Officer · Also traded MIRM in the last 90 days